PBM — Psyence Biomedical Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Psyence Biomedical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.85 | -3.21 | -51.2 | 1.01 | -6.94 |
| Depreciation | |||||
| Non-Cash Items | 0.331 | 0.137 | 49.4 | -4.36 | 0.004 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.129 | 1.48 | -1.17 | -0.386 | -1.22 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.39 | -1.59 | -2.95 | -3.73 | -8.14 |
| Capital Expenditures | — | 0 | -0.006 | -0.01 | -0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.032 | — | — | -0.006 | -4.51 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.032 | 0 | -0.006 | -0.016 | -4.51 |
| Financing Cash Flow Items | -1.62 | 1.17 | 0 | 8.15 | 14 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.62 | 1.17 | 2.35 | 9.15 | 14 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.04 | -0.419 | -0.601 | 5.4 | 1.31 |